Paclitex Paclitaxel 100 Mg Injection

Paclitex Paclitaxel 100 Mg Injection Specification

Dosage Form
Injection

Salt Composition
Paclitaxel 100 mg

Indication
For the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposis sarcoma.

Feature
Sterile, preservative-free, ready-to-use

Ingredients
Paclitaxel, Polyoxyethylated castor oil, Absolute alcohol, and Citric acid.

Application

Ph Level
As per company norms

Physical Color/Texture
Clear, colorless to pale yellow viscous liquid

Fermentation Smell
Normal Smell

Storage Instructions
Dry place

Shelf Life
upto 24 Months

Warning
To be administered under supervision of cancer specialist only

Packaging Size
Single-dose vial, 16.7 ml

Contraindications
Hypersensitivity to Paclitaxel or formulation excipients

Prescription/Non-prescription
Prescription only

Box Contents
One glass vial with leaflet in a carton box

Hazard Precaution
Cytotoxic-handle with care

Administration Route
Intravenous infusion only

Marketed By
Intas Pharmaceuticals Ltd.

Compatibility
Compatible with 0.9% Sodium Chloride and 5% Dextrose solutions

Paclitex Paclitaxel 100 Mg Injection Trade Information

Minimum Order Quantity
100 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7-10 Seconds

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

Main Domestic Market
All India

About Paclitex Paclitaxel 100 Mg Injection

Reserve your trust for Paclitex Paclitaxel 100 Mg Injection, a masterful, sterile, ready-to-use solution for cancer therapy, offered in a single-dose 16.7 ml vial. Engineered for commanding results in the treatment of ovarian, breast, and non-small cell lung cancers, it delivers resplendent value through uncompromised quality under the vigilant eye of oncology specialists. Marketed by Intas Pharmaceuticals, this cytotoxic injection boasts competitive pricing, ensuring broad accessibility while maintaining rigorous safety, compatibility, and shelf-life standards for hospital and clinical use.

Paclitex Paclitaxel 100 Mg Injection: Competitive Edge and Versatility

Paclitex Paclitaxel 100 Mg Injection showcases a commanding presence in oncology with its sterile, preservative-free, clear viscous liquid formulation. Designed for hospital and clinical applications via intravenous infusion, it stands resplendent in versatility-readily compatible with both 0.9% Sodium Chloride and 5% Dextrose. Its distinct single-dose glass vial assures optimal safety, while its ready-to-use, export-oriented packaging affirms masterful quality and streamlined patient care for cancer treatment protocols.

Comprehensive Sample Policy and Efficient Supply Chain

For Paclitex Paclitaxel 100 Mg Injection, quotations are promptly provided upon request to ensure transparent rate comparison and market value assessment. Packaging details feature a singular glass vial and informative leaflet within a carton box, reinforcing product safety. Our supply ability keeps pace with evolving clinical demands, backed by robust distribution channels for timely fulfillment. Sample requests may be accommodated based on institutional guidelines and mutual agreement, supporting institutional evaluation and procurement decisions.

Specification

Brand	Paclitax
Prescription/Non prescription	Prescription
Packaging	Glass Bottle
Treatment	Breast Cancer and Ovarian Cancer.
Manufacturer	Cipla
Packaging Size	16.7 ml
Composition	Paclitaxel
Usage	Hospital,Clinical

FAQ's of Paclitex Paclitaxel 100 Mg Injection:

Q: How should Paclitex Paclitaxel 100 Mg Injection be administered?

A: This injection must be administered only as an intravenous infusion under the supervision of a qualified cancer specialist, strictly following the prescribed dosage and protocol.

Q: What types of cancer can be treated with Paclitex Paclitaxel 100 Mg Injection?

A: Paclitex is indicated for treating ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma as part of a comprehensive chemotherapy regimen.

Q: When should Paclitex be avoided?

A: Use of Paclitex is contraindicated in patients with known hypersensitivity to Paclitaxel or formulation excipients. It should only be given if deemed appropriate by a healthcare provider.

Q: Where is Paclitex Paclitaxel 100 Mg most commonly used?

A: This product is primarily utilized in hospitals and clinical oncology settings where specialized supervision and cytotoxic handling facilities are available.

Q: What are the storage requirements for Paclitex Paclitaxel 100 Mg Injection?

A: Paclitex should be stored in a dry place, adhering to company standards, and used within its 24-month shelf life to maintain product integrity.

Q: How is product compatibility ensured during administration?

A: Paclitex is compatible with common infusion solutions, specifically 0.9% Sodium Chloride and 5% Dextrose, providing flexibility for various clinical procedures.